AN2 Therapeutics, Inc.
ANTX
$1.10
-$0.03-2.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 67.06M | 83.62M | 93.43M | 104.54M | 114.21M |
| Total Receivables | 300.00K | 300.00K | 1.00M | 300.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.20M | 2.34M | 3.26M | 2.60M | 2.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 69.56M | 86.26M | 97.69M | 107.44M | 116.31M |
|
|
|||||
| Total Current Assets | 69.56M | 86.26M | 97.69M | 107.44M | 116.31M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 304.00K | 804.00K | -- | 1.04M | 1.04M |
| Total Assets | 81.34M | 92.09M | 97.69M | 108.48M | 121.26M |
|
|
|||||
| Total Accounts Payable | 3.07M | 3.32M | 1.71M | 1.89M | 2.43M |
| Total Accrued Expenses | 4.57M | 6.13M | 7.03M | 7.68M | 7.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 369.00K | 791.00K | 1.28M | 559.00K | 321.00K |
| Total Other Current Liabilities | 369.00K | 791.00K | 1.28M | 559.00K | 321.00K |
| Total Current Liabilities | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M |
|
|
|||||
| Total Current Liabilities | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.01M | 10.24M | 10.02M | 10.13M | 10.66M |
|
|
|||||
| Common Stock & APIC | 289.71M | 287.59M | 285.81M | 283.89M | 281.62M |
| Retained Earnings | -216.43M | -205.78M | -198.25M | -185.51M | -171.07M |
| Treasury Stock & Other | 48.00K | 31.00K | 112.00K | -27.00K | 53.00K |
| Total Common Equity | 73.33M | 81.85M | 87.67M | 98.35M | 110.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 73.33M | 81.85M | 87.67M | 98.35M | 110.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 73.33M | 81.85M | 87.67M | 98.35M | 110.60M |
|
|
|||||